We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.59B
AUM Growth
+$202M
Cap. Flow
+$46.2M
Cap. Flow %
1.79%
Top 10 Hldgs %
21.22%
Holding
269
New
22
Increased
94
Reduced
105
Closed
21

Top Sells

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$26.6M
2
FTAI icon
FTAI Aviation
FTAI
+$22.8M
3
CRS icon
Carpenter Technology
CRS
+$19.1M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$17.8M
5
VAL icon
Valaris
VAL
+$16.7M

Sector Composition

Rank Sector Weight
1 Technology 24.96%
2 Healthcare 24.88%
3 Industrials 21.18%
4 Financials 12%
5 Consumer Discretionary 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VKTX icon
51
Viking Therapeutics
VKTX
$4.31B
$21.5M 0.83%
339,047
+12,001
+4% +$704K
SPXC icon
52
SPX Corp
SPXC
$10.6B
$21.1M 0.81%
132,051
+38,161
+41% +$5.76M
MTSI icon
53
MACOM Technology Solutions
MTSI
$20.4B
$20.7M 0.8%
186,478
-83,942
-31% -$8.8M
TREE icon
54
LendingTree
TREE
$645M
$20.7M 0.8%
356,389
+10,497
+3% +$542K
NSSC icon
55
Napco Security Technologies
NSSC
$1.29B
$20.6M 0.8%
508,257
+19,674
+4% +$964K
KLIC icon
56
Kulicke & Soffa
KLIC
$5.09B
$20.4M 0.79%
452,945
+9,943
+2% +$440K
TDW icon
57
Tidewater
TDW
$3.77B
$19M 0.74%
265,037
-4,986
-2% -$434K
BJRI icon
58
BJ's Restaurants
BJRI
$1.42B
$18.5M 0.72%
569,221
+4,009
+0.7% +$129K
CCOI icon
59
Cogent Communications
CCOI
$549M
$18.3M 0.71%
241,249
+6,647
+3% +$458K
CHDN icon
60
Churchill Downs
CHDN
$5.85B
$17.6M 0.68%
129,844
-6,461
-5% -$893K
PTLO icon
61
Portillo's
PTLO
$338M
$17.1M 0.66%
1,272,214
+288,675
+29% +$3.22M
ARHS icon
62
Arhaus
ARHS
$1.09B
$16.9M 0.65%
1,371,567
+32,077
+2% +$433K
BPOP icon
63
Popular Inc
BPOP
$11.1B
$16.5M 0.64%
164,982
+38,409
+30% +$3.74M
CDMO
64
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$16.5M 0.64%
+1,448,916
New +$14.5M
SYNA icon
65
Synaptics
SYNA
$4.46B
$16.1M 0.62%
207,287
+5,004
+2% +$401K
SLNO
66
DELISTED
Soleno Therapeutics
SLNO
$15.8M 0.61%
313,334
+20,006
+7% +$958K
XPRO icon
67
Expro Ltd
XPRO
$1.87B
$15.6M 0.6%
907,451
+321,873
+55% +$6.55M
CLDX icon
68
Celldex Therapeutics
CLDX
$2.77B
$15.5M 0.6%
456,202
+257,773
+130% +$9.82M
WHD icon
69
Cactus
WHD
$3.78B
$15.2M 0.59%
254,763
-4,063
-2% -$236K
AKRO
70
DELISTED
Akero Therapeutics
AKRO
$15M 0.58%
524,427
+9,175
+2% +$239K
ONTO icon
71
Onto Innovation
ONTO
$13.9B
$14.8M 0.57%
71,192
-54,225
-43% -$10.9M
RHP icon
72
Ryman Hospitality Properties
RHP
$7.99B
$14.2M 0.55%
132,663
-1,811
-1% -$185K
ONT
73
Onterris Inc
ONT
$756M
$13.8M 0.53%
525,552
-210,547
-29% -$6.81M
TRNO icon
74
Terreno Realty
TRNO
$7.94B
$13.8M 0.53%
205,861
-2,477
-1% -$167K
TTMI icon
75
TTM Technologies
TTMI
$13.7B
$13.7M 0.53%
+750,280
New +$14.5M

Similar funds

Emerald Advisers's Q3 2024 Portfolio in Review

As of Q3 2024, Emerald Advisers held 269 positions worth $2.59B, up 8.5% from $2.38B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Emerald Advisers's Q3 2024 filing shows 22 new, 94 increased, 105 reduced and 21 closed positions. Its largest new stake was Avid Bioservices, Inc. Common Stock: 1,448,916 shares worth $16.5M. The largest sale was Transmedics, an estimated $26.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

  • Emerald Advisers's largest Q3 2024 buy was Avid Bioservices, Inc. Common Stock: 1,448,916 shares worth $16.5M.
  • Emerald Advisers added most to Fulton Financial in Q3 2024, an estimated $16.2M increase.
  • Emerald Advisers's biggest Q3 2024 reduction was Transmedics, cutting an estimated $26.6M.
  • Emerald Advisers fully exited Savers in Q3 2024, selling an estimated $9.16M.
  • Emerald Advisers's ten largest holdings make up 21% of its $2.59B portfolio in Q3 2024.
  • Emerald Advisers opened 22 new positions and closed 21 in Q3 2024.
  • Emerald Advisers's portfolio value rose 8.5% quarter-over-quarter to $2.59B.

Based on Emerald Advisers's 13F filing for Q3 2024, filed 29 Oct 2024.